Perimenopause rarely announces itself politely. For most women it arrives as a rotating cast of symptoms — fatigue one month, broken sleep the next, then mood swings, skin changes, and a waistline that stops responding to the usual effort. Because the symptoms are so varied, “the best peptide for perimenopause” is really six different questions. This guide organizes the research compound by compound, matched to the symptom each is actually studied for.
For Fatigue and Energy: NAD+
Deep, cellular-level fatigue is one of the most common perimenopause complaints, and NAD+ is the compound most discussed for it. NAD+ is a coenzyme central to cellular energy metabolism, and its levels decline with age. Research interest centers on whether restoring the NAD+ pool supports mitochondrial function and subjective energy. For women weighing options in this category, our comparison of SS-31 vs NAD+ for perimenopause fatigue goes deeper, and the NAD+ overview covers delivery methods and research status.
For Sleep Disruption: DSIP
Waking at 3 a.m. and staring at the ceiling is practically a perimenopause rite of passage. DSIP — delta sleep-inducing peptide — is researched specifically for sleep architecture, the structure and depth of sleep stages rather than simple sedation. It is one of the older peptides in the research literature, with a mixed but interesting evidence base. It often appears paired with Selank in sleep-and-mood stacks because disrupted sleep and mood changes tend to feed each other.
For Mood and Anxiety: Selank
Fluctuating estrogen affects neurotransmitter systems, which is why anxiety can spike during perimenopause even in women who have never struggled with it. Selank’s research profile centers on anxiety and stress-response modulation without the sedation or dependence concerns associated with traditional anxiolytics. The research is largely from Russian clinical literature, which is worth knowing when weighing the evidence.
For Weight and Metabolic Shifts: GLP-1s and Tesamorelin
Midsection weight gain during perimenopause reflects real physiology — estrogen decline shifts fat storage toward visceral fat while muscle mass quietly erodes. The compounds with the most relevant evidence are the prescription GLP-1 class for overall weight and appetite, and tesamorelin for visceral fat specifically. We cover both in depth, including realistic expectations, in peptides for menopause weight loss.
For Skin and Collagen: GHK-Cu
Collagen loss accelerates sharply as estrogen falls — the skin changes many women notice in their 40s are not imagination. GHK-Cu, a copper-binding peptide, is one of the better-researched topical and cosmetic peptides, with studies focused on collagen synthesis, skin repair, and remodeling. It is also one of the few compounds on this page with a meaningful topical delivery route.
For Libido: PT-141
Declining desire during perimenopause has both hormonal and neurological components. PT-141 (bremelanotide) is distinctive because it works through melanocortin receptors in the nervous system rather than through hormones or blood flow — and its approved form, Vyleesi, was studied specifically in premenopausal women with hypoactive sexual desire disorder. Our PT-141 overview covers mechanisms, the approval, and side effects.
What About Irregular Cycles and Hormones Directly?
No research peptide “fixes” perimenopausal hormone fluctuation, and anyone claiming otherwise is selling something. Kisspeptin is genuinely interesting science — it sits upstream of the reproductive hormone axis and is being studied clinically — but it is a research story, not a treatment you use at home; see our kisspeptin overview. For the broader question of compounds relevant to hormonal wellness, our guide to the best peptide for female hormone balance separates what has evidence from what has marketing. Hormone therapy itself remains a conversation for your provider — and for many women it is the right first conversation.
How to Choose a Starting Point
Start with your most disruptive symptom, not the longest stack. One compound at a time makes it possible to tell what is actually helping. A reasonable sequence: identify the symptom costing you the most quality of life, read the research on the one or two compounds relevant to it, and bring that shortlist to a provider who works with midlife women.